 By Brian Marckx, CFA NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Fiscal Q3 2020 Financials, Operational Update Aethlon NASDAQ:AEMD reported fiscal Q3 2020 financial results and provided an operational update. Relative to the latter, which we discuss in more detail below, highlights include the possibility that the Hemopurifier might be tested as a potential therapy against the ongoing 